Marina Danckaerts

ORCID: 0000-0002-7168-963X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Attention Deficit Hyperactivity Disorder
  • Child and Adolescent Psychosocial and Emotional Development
  • Neural and Behavioral Psychology Studies
  • Children's Physical and Motor Development
  • Functional Brain Connectivity Studies
  • Behavioral and Psychological Studies
  • Pharmaceutical studies and practices
  • Autism Spectrum Disorder Research
  • Cognitive Abilities and Testing
  • Psychiatric care and mental health services
  • EEG and Brain-Computer Interfaces
  • Sleep and related disorders
  • Bipolar Disorder and Treatment
  • Child Nutrition and Feeding Issues
  • Childhood Cancer Survivors' Quality of Life
  • Mental Health Treatment and Access
  • Cancer-related cognitive impairment studies
  • Perfectionism, Procrastination, Anxiety Studies
  • Child and Adolescent Health
  • Maternal Mental Health During Pregnancy and Postpartum
  • Obsessive-Compulsive Spectrum Disorders
  • Youth Substance Use and School Attendance
  • Adolescent and Pediatric Healthcare
  • Schizophrenia research and treatment
  • Family and Disability Support Research

KU Leuven
2016-2025

VIB-KU Leuven Center for Brain & Disease Research
2023

University Psychiatric Hospital
2022

Radboud University Nijmegen
2004-2022

Radboud University Medical Center
2004-2022

Ghent University
2021

VIB-KU Leuven Center for Microbiology
2017-2019

Centrum für Integrierte Onkologie
2017

Universitair Ziekenhuis Leuven
2004-2016

Huntsman (Belgium)
2014

10.1097/00004583-199609000-00019 article EN Journal of the American Academy of Child & Adolescent Psychiatry 1996-09-01

The safety of ADHD medications is not fully known. Concerns have arisen about both a lack contemporary-standard information first licensed several decades ago, and signals possible harm arising from more recently developed medications. These relate to relatively minor adverse effects extremely serious issues such as sudden cardiac death suicidality. A guidelines group the European Network for Hyperkinetic Disorders (EUNETHYDIS) has therefore reviewed literature, recruited renowned clinical...

10.1007/s00787-010-0140-6 article EN cc-by-nc European Child & Adolescent Psychiatry 2010-11-02

The coronavirus disease 2019 (COVID-19) pandemic is creating unprecedented challenges at every level of society. Individuals with neurodevelopmental disorders, such as attention-deficit hyperactivity disorder (ADHD), are particularly vulnerable to the distress caused by and physical distancing measures, they might display increased behavioural problems. crisis also poses several important questions for clinicians on how best deliver care within new restrictions. Therefore, European ADHD...

10.1016/s2352-4642(20)30110-3 article EN other-oa The Lancet Child & Adolescent Health 2020-04-17

Background: The need for accessible and motivating treatment approaches within mental health has led to the development of an Internet-based serious game intervention (called “Plan-It Commander”) as adjunct usual children with attention-deficit/hyperactivity disorder (ADHD). Objective: aim was determine effects Plan-It Commander on daily life skills ADHD in a multisite randomized controlled crossover open-label trial. Methods: Participants (N=170) this 20-week trial had diagnosis...

10.2196/jmir.5173 article EN cc-by Journal of Medical Internet Research 2016-02-16

The need for engaging treatment approaches within mental health care has led to the application of gaming existing behavioral training programs (i.e., gamification). Because children with attention deficit/hyperactivity disorder (ADHD) tend have fewer problems concentration and engagement when playing digital games, applying game technologies design complement may be a useful means engage this population in their treatment. Unfortunately, gamified currently available ADHD been limited...

10.1089/g4h.2015.0021 article EN Games for Health Journal 2015-09-01

In this study we examined the effectiveness of atomoxetine for treatment oppositional defiant disorder comorbid with attention-deficit/hyperactivity disorder.Patients were aged 6 to 12 years and met Diagnostic Statistical Manual Mental Disorders, Fourth Edition, diagnostic criteria a Swanson, Nolan, Pelham Rating Scale-Revised subscale score above age gender norms; Clinical Global Impressions-Severity Scale > or = 4; 15. Patients randomly assigned in 2:1 ratio receive 1.2 mg/kg per day (n...

10.1542/peds.2006-1880 article EN PEDIATRICS 2008-02-01
Coming Soon ...